Related Experiment Video
Updated: Apr 14, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
22.2K
[Management in advanced germ-cell tumors--report of two cases]
Akusherstvo I Ginekologiia
|April 25, 2015
Abstract:
The germ-cells tumors are the most common ovarian malignancy in young women between 15-25 years. Often advanced disease is present at the time of diagnosis. The management and treatment approaches of disgerminoma and immature teratoma, as most common germ-cells tumors (GST), are presented. Two clinical cases of advanced stages of GST with complete remision after conservative surgical treatment and chemotherapy have been reviewed.
Related Concept Videos
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
02:56Treatment Resistent Cancers
1.5K
1.5K
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K